Coltra 500 500 mg Suppositories
PDF Leaflet Revision Date: 22 March 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment and maintenance of remission in ulcerative colitis.
Dosage (summary)
One suppository rectally up to three times daily for adults.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- NSAIDs
- Azathioprine
- Warfarin
Contraindications
- Hypersensitivity to mesalazine
- Severe liver impairment
- GFR < 30 ml/min
- History of salicylate allergy
Common side effects
- Abdominal pain
Counselling Points
- Monitor for signs of hypersensitivity
- Ensure adequate fluid intake
- Report any unexplained bleeding or bruising
Serious warnings
- Severe cutaneous adverse reactions
- Nephrotoxicity
- Blood dyscrasia
Important Disclaimer
The Coltra 500 500 mg Suppositories professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
